Ernest Pharmaceuticals

11:45 AM - 12:00 PM, Tuesday, June 4,2019 ・ SuS - Hall E, Booth 3971, Level 200
Therapeutics company utilizing therapeutic bacteria that actively penetrate tumor tissue to treat metastatic disease and tumors. This type of bacteria accumulates in tumors and metastases which enables delivery to malignant tissue and avoids healthy organs. This allows for the development of effective and potent cancer therapy drug delivery by programming the bacteria and accessing the cancerous tissue via targeting mechanisms.
Speaker
photo
CSO
Ernest Pharmaceuticals